This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simon, R. Articles by Böcker, W. Search for Related Content PubMed PubMed Citation Articles by Simon, R. Articles by Böcker, W.

Cytogenetic Analysis of Multifocal Bladder Cancer Supports a Monoclonal Origin and Intraepithelial Spread of Tumor Cells¹

Gerhard-Domagk-Institute of Pathology [R. S., E. E., K-L. S., H. B., B. D-D., W. B.] and Department of Urology [A. S., L. H.], University of Münster, D-48149 Münster, and Institute of Pathology, Klinikum Leverkusen, D-51375 Leverkusen [H-J. T.], Germany

Bladder cancer is often characterized by a multifocal growth pattern. This observation has given rise to the hypothesis of "field cancerization," predicting a polyclonal origin of multiple tumors rising from an area of independently transformed mucosa cells. On the other hand, genetic studies suggested a monoclonal origin. To address these contradictory hypotheses, we performed comparative genomic hybridization (CGH) on 32 tumors originating from six bladder cystectomy specimens. All tumors derived from the same patient showed a set of 7–13 identical chromosomal aberrations and additional individual alterations. Most striking were the findings of 17p losses in all (32 of 32) tumors of the six cystectomy specimens and 20p gains in all tumors of four bladders, as well as an unexpected high number of chromosomal changes (20.4 alterations per tumor on average). To clarify a possible role of the TP53 tumor suppressor gene on 17p13, we applied immunohistochemistry and sequence analysis on the tumors and additional 52 mucosa samples. Identical TP53 mutations and protein overexpression was found in individual tumors only as well as in mucosa samples from continuous areas. Our results not only provide further evidence for a monoclonal origin of multifocal bladder cancer but also point at intraepithelial migration of tumor cells carrying specific chromosomal aberrations.

This article has been cited by other articles:

				G. C Santos, M Zielenska, M Prasad, and J A Squire Chromosome 6p amplification and cancer progression J. Clin. Pathol., January 1, 2007; 60(1): 1 - 7. [Abstract] [Full Text] [PDF]

				T. D. Jones, M. Wang, J. N. Eble, G. T. MacLennan, A. Lopez-Beltran, S. Zhang, A. Cocco, and L. Cheng Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis Clin. Cancer Res., September 15, 2005; 11(18): 6512 - 6519. [Abstract] [Full Text] [PDF]

				E. S. Kim and W. K. Hong An Apple a Day...Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention J Natl Cancer Inst, April 6, 2005; 97(7): 468 - 470. [Full Text] [PDF]

				M Gallucci, F Guadagni, R Marzano, C Leonardo, R Merola, S Sentinelli, E M Ruggeri, R Cantiani, I Sperduti, F d. l. I Lopez, et al. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters J. Clin. Pathol., April 1, 2005; 58(4): 367 - 371. [Abstract] [Full Text] [PDF]

				A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]

				A. J. Evans, B. L. Gallie, M. A.S. Jewett, G. R. Pond, K. Vandezande, J. Underwood, Y. Fradet, G. Lim, P. Marrano, M. Zielenska, et al. Defining a 0.5-Mb Region of Genomic Gain on Chromosome 6p22 in Bladder Cancer by Quantitative-Multiplex Polymerase Chain Reaction Am. J. Pathol., January 1, 2004; 164(1): 285 - 293. [Abstract] [Full Text] [PDF]

				B. J. M. Braakhuis, M. P. Tabor, J. A. Kummer, C. R. Leemans, and R. H. Brakenhoff A Genetic Explanation of Slaughter's Concept of Field Cancerization: Evidence and Clinical Implications Cancer Res., April 15, 2003; 63(8): 1727 - 1730. [Abstract] [Full Text] [PDF]

				M. A. Harding, K. C. Arden, J. W. Gildea, J. J. Gildea, E. J. Perlman, C. Viars, and D. Theodorescu Functional Genomic Comparison of Lineage-related Human Bladder Cancer Cell Lines with Differing Tumorigenic and Metastatic Potentials by Spectral Karyotyping, Comparative Genomic Hybridization, and a Novel Method of Positional Expression Profiling Cancer Res., December 1, 2002; 62(23): 6981 - 6989. [Abstract] [Full Text] [PDF]

				A. Hartmann, G. Schlake, D. Zaak, E. Hungerhuber, A. Hofstetter, F. Hofstaedter, and R. Knuechel Occurrence of Chromosome 9 and p53 Alterations in Multifocal Dysplasia and Carcinoma in Situ of Human Urinary Bladder Cancer Res., February 1, 2002; 62(3): 809 - 818. [Abstract] [Full Text] [PDF]

				G. Dalbagni, Z.-P. Ren, H. Herr, C. Cordon-Cardo, and V. Reuter Genetic Alterations in TP53 in Recurrent Urothelial Cancer: A Longitudinal Study Clin. Cancer Res., September 1, 2001; 7(9): 2797 - 2801. [Abstract] [Full Text] [PDF]